Infect Chemother.  2018 Sep;50(3):283-285. 10.3947/ic.2018.50.3.283.

Exploring New Predictors of Colistin-Associated Nephrotoxicity

Affiliations
  • 1Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
  • 2Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. eskim@snubh.org
  • 3Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Abstract

No abstract available.


Reference

1. Rigatto MH, Oliveira MS, Perdigão-Neto LV, Levin AS, Carrilho CM, Tanita MT, Tuon FF, Cardoso DE, Lopes NT, Falci DR, Zavascki AP. Multicenter prospective cohort study of renal failure in patients treated with colistin versus polymyxin B. Antimicrob Agents Chemother. 2016; 60:2443–2449. PMID: 26856846.
Article
2. Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009; 22:535–543. PMID: 19797945.
Article
3. Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, Lephart P, Kaye KS. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011; 53:879–884. PMID: 21900484.
Article
4. Ko HJ, Jeon MH, Choo EJ, Lee EJ, Kim TH, Jun JB, Gil HW. Early acute kidney injury is a risk factor that predicts mortality in patients treated with colistin. Nephron Clin Pract. 2011; 117:c284–c288. PMID: 20847571.
Article
5. Sorlí L, Luque S, Grau S, Berenguer N, Segura C, Montero MM, Alvarez-Lerma F, Knobel H, Benito N, Horcajada JP. Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study. BMC Infect Dis. 2013; 13:380. PMID: 23957376.
Article
6. Kim J, Lee KH, Yoo S, Pai H. Clinical characteristics and risk factors of colistin-induced nephrotoxicity. Int J Antimicrob Agents. 2009; 34:434–438. PMID: 19726164.
Article
7. Ordooei Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol. 2015; 71:801–810. PMID: 26008213.
Article
8. Shavit L, Manilov R, Wiener-Well Y, Algur N, Slotki I. Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin. Clin Nephrol. 2013; 80:405–416. PMID: 24120670.
Article
9. Park SY, Eom JS, Lee JS, Ju YS, Park JY. Neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in patients during treatment with colistimethate sodium. Infect Chemother. 2018; 50:128–137. PMID: 29968980.
Article
10. Keirstead ND, Wagoner MP, Bentley P, Blais M, Brown C, Cheatham L, Ciaccio P, Dragan Y, Ferguson D, Fikes J, Galvin M, Gupta A, Hale M, Johnson N, Luo W, McGrath F, Pietras M, Price S, Sathe AG, Sasaki JC, Snow D, Walsky RL, Kern G. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci. 2014; 137:278–291. PMID: 24189134.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr